<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">
    oju
   </journal-id>
   <journal-title-group>
    <journal-title>
     Open Journal of Urology
    </journal-title>
   </journal-title-group>
   <issn pub-type="epub">
    2160-5440
   </issn>
   <issn publication-format="print">
    2160-5629
   </issn>
   <publisher>
    <publisher-name>
     Scientific Research Publishing
    </publisher-name>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="doi">
    10.4236/oju.2025.158040
   </article-id>
   <article-id pub-id-type="publisher-id">
    oju-145069
   </article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>
      Articles
     </subject>
    </subj-group>
    <subj-group subj-group-type="Discipline-v2">
     <subject>
      Medicine 
     </subject>
     <subject>
       Healthcare
     </subject>
    </subj-group>
   </article-categories>
   <title-group>
    Efficacy of Holmium Laser Lithotripsy and Shock Pulse Lithotripsy in Terms of Stone Clearance Rate in Patients with Upper Ureteric Calculus in a Tertiary Care Centre: A Prospective Observational Study
   </title-group>
   <contrib-group>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Chezhian
      </surname>
      <given-names>
       Subramanian
      </given-names>
     </name>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Ankur
      </surname>
      <given-names>
       Mittal
      </given-names>
     </name>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Vikas Kumar
      </surname>
      <given-names>
       Panwar
      </given-names>
     </name>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Gurpremjit
      </surname>
      <given-names>
       Singh
      </given-names>
     </name>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Omang
      </surname>
      <given-names>
       Agrawal
      </given-names>
     </name>
    </contrib>
   </contrib-group> 
   <aff id="affnull">
    <addr-line>
     aDepartment of Urology, All India Institute of Medical Sciences, Rishikesh, India
    </addr-line> 
   </aff> 
   <pub-date pub-type="epub">
    <day>
     05
    </day> 
    <month>
     08
    </month>
    <year>
     2025
    </year>
   </pub-date> 
   <volume>
    15
   </volume> 
   <issue>
    08
   </issue>
   <fpage>
    397
   </fpage>
   <lpage>
    407
   </lpage>
   <history>
    <date date-type="received">
     <day>
      26,
     </day>
     <month>
      January
     </month>
     <year>
      2025
     </year>
    </date>
    <date date-type="published">
     <day>
      22,
     </day>
     <month>
      January
     </month>
     <year>
      2025
     </year> 
    </date> 
    <date date-type="accepted">
     <day>
      22,
     </day>
     <month>
      August
     </month>
     <year>
      2025
     </year> 
    </date>
   </history>
   <permissions>
    <copyright-statement>
     © Copyright 2014 by authors and Scientific Research Publishing Inc. 
    </copyright-statement>
    <copyright-year>
     2014
    </copyright-year>
    <license>
     <license-p>
      This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/
     </license-p>
    </license>
   </permissions>
   <abstract>
    <b>Introduction: </b>As the popularity of retrograde ureteroscopy continues to rise, it is becoming more common for patients to have it done for the treatment of ureteric calculi. Although the use of new technologies such as laser and shock pulse lithotripsy has increased the number of options for the treatment of proximal calculi, the exact guidelines regarding the optimal energy source for this condition in URSL is still not clear. 
    <b>Materials and </b>
    <b>Methods</b>
    <b>: </b>This is a prospective observational pilot study done in the Department of Urology, AIIMS Rishikesh from September 2020 till June 2022 with sample size of 30 in each arm (Holmium Laser—HL and Shock Pulse—SP) involving those participants planned for either Holmium Laser or shock pulse Ureteroscopic lithotripsy fulfilling inclusion and exclusion criteria. 
    <b>Results: </b>In our study we have found that stone clearance rate of shock pulse (HL and SP, 8.028 ± 3.69 and 12.70 ± 8.19 mm
    <sup>3</sup>/mins, p value: 0.05) to be significantly higher than Holmium laser lithotripsy. We have also found significant reduction in operating time (64.68 ± 10.62 mins and 36.78 ± 5.24 mins, p value &lt; 0.05). Stone fragmentation quality of shock pulse is superior to that of Holmium Laser (Time taken for stone fragmentation, HL and SP, 59.09 ± 10.47 mins and 32.75 ± 7.53 mins, p value &lt; 0.05). 
    <b>Conclusion: </b>Our study has aided in better understanding the efficacy of the two lithotripter modalities. In order to build a deeper knowledge of the benefits and drawbacks connected with the device, large sample size and long term follow up are required.
   </abstract>
   <kwd-group> 
    <kwd>
     Ureteric Calculi
    </kwd> 
    <kwd>
      Ureteroscopy
    </kwd> 
    <kwd>
      URSL
    </kwd> 
    <kwd>
      Shock Pulse Lithotripsy
    </kwd> 
    <kwd>
      Holmium Laser Lithotripsy
    </kwd> 
    <kwd>
      Stone Clearance Rate
    </kwd> 
    <kwd>
      Stone Fragmentation Quality
    </kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <sec id="s1">
   <title>1. Introduction</title>
   <p>Due to changing socio-economic conditions the prevalence and incidence of the upper urinary tract stones are on the rising trend <xref ref-type="bibr" rid="scirp.145069-1">
     [1]
    </xref>. In Asia, the prevalence of urolithiasis is about 1% - 19.1% <xref ref-type="bibr" rid="scirp.145069-2">
     [2]
    </xref>.</p>
   <p>There has been a dynamic progress in the management of urolithiasis over years. With the advancement in the endourological interventions over the last 30 years, the complications following endourological intervention are minor and do not require intervention <xref ref-type="bibr" rid="scirp.145069-3">
     [3]
    </xref>.</p>
   <p>Pharmacological treatment (medical expulsion therapy—MET) can be started in cases of uncomplicated ureteric stones of size less than 10 mm . Beyond this size, the success rate of pharmacological treatment decreases and there is a need for surgical intervention .</p>
   <p>Ureteroscopy (URS), Extracorporeal shock wave Lithotripsy (ESWL) and Percutaneous Nephrolithotripsy (PCNL) are techniques frequently used in recent days replacing open surgery <xref ref-type="bibr" rid="scirp.145069-5">
     [5]
    </xref> <xref ref-type="bibr" rid="scirp.145069-6">
     [6]
    </xref>. Various techniques have been used for stone fragmentation and include pneumatic, ultrasonic, electrohydraulic, and laser lithotripsy out of which pneumatic and laser lithotripsy are commonly used <xref ref-type="bibr" rid="scirp.145069-7">
     [7]
    </xref> <xref ref-type="bibr" rid="scirp.145069-8">
     [8]
    </xref>.</p>
   <p>In Ureteroscopic removal of calculus, various lithotripters with different energy sources are being used in fragmentation of calculus and the mechanisms of each lithotripter is unique. Holmium: YAG laser lithotripsy works by producing laser energy which gets absorbed by the ureteric stone leading to thermal combustion and also creates a vaporization bubble which will destabilize and decompose the calculus. Shock pulse is a lithotripter approved by the FDA in 2014. Shock Pulse lithotripter uses low frequency mechanical/pneumatic and high-frequency ultrasonic energy in breaking down and evacuating the calculus. Ultrasonic energy is sufficient in breaking down softer components of calculus and pneumatic energy is used in breaking the hard components <xref ref-type="bibr" rid="scirp.145069-7">
     [7]
    </xref>-<xref ref-type="bibr" rid="scirp.145069-10">
     [10]
    </xref>.</p>
   <p>For proximal ureteric stones ≥ 10 mm URS offers high success rate as a primary procedure when compared with SWL <xref ref-type="bibr" rid="scirp.145069-9">
     [9]
    </xref>. Moreover, Ureteroscopic stone removal can be done as outpatient procedure was found to be more beneficial and economical <xref ref-type="bibr" rid="scirp.145069-10">
     [10]
    </xref>. Several authors have reported Ureteroscopic stone removal as an alternative for PCNL in the removal of large renal stones also and also the efficacy and safety of URS are improving day by day.</p>
   <p>Various studies have been done in order to find out the appropriate management for ureteric calculus but to the best of our knowledge, no research has been conducted in the world to compare the efficacy of Holmium laser and shock pulse lithotripsy in terms of stone clearance rate in patients with upper ureteric calculus via ureteroscopic removal. Thus, this study will help us in finding the lithotripter with effective stone clearance rate and also in choosing the appropriate lithotripsy technique in the management of upper ureteric calculus.</p>
  </sec><sec id="s2">
   <title>2. Methods</title>
   <p>We have conducted a two-arm nonrandomized prospective observational pilot study in the Department of Urology, AIIMS Rishikesh, after obtaining Ethical clearance. A total of 64 patients visiting the department of Urology were included from September 2020 till June 2022 based on the pre specified selection criteria.</p>
   <p>Inclusion Criteria: Participants ≥ 18 years of age with Solitary upper ureteric calculus ≤ 1.5 cm in maximum diameter as measured on preoperative CT scan who are willing and able to provide informed consent to undergo Ureteroscopic lithotripsy as treatment.</p>
   <p>Exclusion Criteria: Pregnant females and Patients with urinary tract infections are excluded.</p>
   <p>Sampling Technique: All consecutive patients meeting the inclusion and exclusion criteria were included in this study until the desired sample size was achieved (30 in each arm). Minimum sample size of 30 was taken in each arm in view of observational pilot study.</p>
   <p>Sampling Method: All consecutive patients above 18 years of age who are diagnosed to have upper ureteric calculus willing to take part were included in this study. This will be a non-randomized prospective observational pilot study and individuals were enrolled into the study if the inclusion criteria were fulfilled. Written consent has been obtained from the participants after explaining the aims, objectives, plan and duration of the study in a language which they are able to understand better.</p>
   <p>During the study, demographic and patient data was recorded. Baseline evaluation of each participant will be carried out. After this work up patients were randomized into any one of the following groups (Holmium laser—HL and Shock Pulse—SP). Ureteroscopic lithotripsy was performed using any one of the lithotripters in the Operating Room, Department of Urology by the Surgeon. After fragmentation of the calculus DJ stent will placed in the ureteric tract.</p>
   <p>Following Parameters Has Been Evaluated: Preoperatively Stone volume (mm<sup>3</sup>) &amp; Stone density (Hounsfield units, HU) are assessed by CT-Urography or NCCT-KUB &amp; Diuretic Renal scan (in case of mild CKD). Intraoperatively, Operating time (OT) (Time interval between ureteroscope insertion and removal following stone fragmentation through urethra), Time taken for stone fragmentation and extraction (Time interval between the start of lithotripter unit for fragmentation till the removal of all fragments the ureter, based on visual inspection prior to the last visual inspection through the ureteroscope) were noted. Post operatively stone clearance rate (Stone volume divided by time taken for stone fragmentation and extraction), stone volume at post operative day 10 &amp; after 4 weeks were assessed. If no fragments, individual was considered as stone free. Residual stone if any was assessed (if ≤ 2 mm: Clinically Insignificant Residual fragments (CIRF), ≥2 mm: Failed). Complications if any was assessed and classified according to Clavien Dindo classification. On post operative day 1, Xray KUB was used to assess the position of the DJ stent. On post operative day 10, NCCT KUB was used for assessment following stent removal. Routine follow up at 4 weeks.</p>
  </sec><sec id="s3">
   <title>3. Statistical Analysis</title>
   <p>Data was entered in Microsoft Excel spreadsheet.</p>
   <p>Categorical variables described as frequency and proportion. Continuous variables described as mean ± standard deviation or median with inter-quartile range as applicable.</p>
   <p>We compared proportions by using Chi-square test, Fishers exact test as and when required. Student’s t-test and Mann Whitney U test used to compare means between two groups. Paired t-test used to compare readings of continuous variables at two points of time. All statistical tests will be performed with a significance level of a = 0.05 (95% C.I) and analysis will be conducted using IBM SPSS STATISTICS (version 23.0).</p>
  </sec><sec id="s4">
   <title>4. Results</title>
   <p>Most our participants were in the range of 31 - 60 years of age, comprising of 19 (59.4%) and 17 (53.1%) out of 32 in each group. From our data we can conclude that majority of our participants belong to young and middle age group. Mean age was found to be 39.3 ± 12.2 and 37.4 ± 14.4 in HL and SP group respectively (<xref ref-type="table" rid="table1">
     Table 1
    </xref>). No significant statistical difference was found in age group on analysis. In our study Males were predominant, 23 (71.9%) while Females where about 9 (28.1%) in each group (<xref ref-type="table" rid="table1">
     Table 1
    </xref>). Mean height and mean weight was found to be similar in both groups. More than 50% of our participants were in the normal BMI range in both the groups.</p>
   <table-wrap id="table1">
    <label>
     <xref ref-type="table" rid="table1">
      Table 1
     </xref></label>
    <caption>
     <title>
      <xref ref-type="bibr" rid="scirp.145069-"></xref>Table 1. Table showing distribution of patients as per age, gender and its p-value.</title>
    </caption>
    <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
     <tr> 
      <td rowspan="2" class="acenter" width="31.62%"><p style="text-align:center">Age category (in years)</p></td> 
      <td class="acenter" width="53.28%" colspan="2"><p style="text-align:center">Procedure Performed</p></td> 
      <td rowspan="2" class="acenter" width="15.10%"><p style="text-align:center">p Value</p></td> 
     </tr> 
     <tr> 
      <td class="custom-bottom-td custom-top-td acenter" width="26.64%"><p style="text-align:center">HL</p></td> 
      <td class="custom-bottom-td custom-top-td acenter" width="26.64%"><p style="text-align:center">SP</p></td> 
     </tr> 
     <tr> 
      <td class="custom-top-td acenter" width="31.62%"><p style="text-align:center">&lt;30</p></td> 
      <td class="custom-top-td acenter" width="26.64%"><p style="text-align:center">11 (34.4%)</p></td> 
      <td class="custom-top-td acenter" width="26.64%"><p style="text-align:center">13 (40.6%)</p></td> 
      <td rowspan="4" class="custom-top-td acenter" width="15.10%"><p style="text-align:center">0.870</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="31.62%"><p style="text-align:center">31 - 60</p></td> 
      <td class="acenter" width="26.64%"><p style="text-align:center">19 (59.4%)</p></td> 
      <td class="acenter" width="26.64%"><p style="text-align:center">17 (53.1%)</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="31.62%"><p style="text-align:center">&gt;61</p></td> 
      <td class="acenter" width="26.64%"><p style="text-align:center">2 (6.3%)</p></td> 
      <td class="acenter" width="26.64%"><p style="text-align:center">2 (6.3%)</p></td> 
     </tr> 
     <tr> 
      <td class="custom-bottom-td acenter" width="31.62%"><p style="text-align:center">Total</p></td> 
      <td class="custom-bottom-td acenter" width="26.64%"><p style="text-align:center">32 (100%)</p></td> 
      <td class="custom-bottom-td acenter" width="26.64%"><p style="text-align:center">32 (100%)</p></td> 
     </tr> 
     <tr> 
      <td class="custom-bottom-td custom-top-td acenter" width="31.62%"><p style="text-align:center">Mean ± SD (in years)</p></td> 
      <td class="custom-bottom-td custom-top-td acenter" width="26.64%"><p style="text-align:center">39.3 ± 12.2</p></td> 
      <td class="custom-bottom-td custom-top-td acenter" width="26.64%"><p style="text-align:center">37.4 ± 14.4</p></td> 
      <td class="custom-bottom-td custom-top-td acenter" width="15.10%"><p style="text-align:center">0.570</p></td> 
     </tr> 
     <tr> 
      <td rowspan="2" class="custom-top-td acenter" width="31.62%"><p style="text-align:center">Gender</p></td> 
      <td class="custom-bottom-td custom-top-td acenter" width="53.28%" colspan="2"><p style="text-align:center">Procedure performed</p></td> 
      <td rowspan="2" class="custom-top-td acenter" width="15.10%"><p style="text-align:center"></p></td> 
     </tr> 
     <tr> 
      <td class="custom-bottom-td custom-top-td acenter" width="26.64%"><p style="text-align:center">HL</p></td> 
      <td class="custom-bottom-td custom-top-td acenter" width="26.64%"><p style="text-align:center">SP</p></td> 
     </tr> 
     <tr> 
      <td class="custom-top-td acenter" width="31.62%"><p style="text-align:center">Female</p></td> 
      <td class="custom-top-td acenter" width="26.64%"><p style="text-align:center">9 (28.1%)</p></td> 
      <td class="custom-top-td acenter" width="26.64%"><p style="text-align:center">9 (28.1%)</p></td> 
      <td rowspan="3" class="custom-top-td acenter" width="15.10%"><p style="text-align:center">1.000</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="31.62%"><p style="text-align:center">Male</p></td> 
      <td class="acenter" width="26.64%"><p style="text-align:center">23 (71.9%)</p></td> 
      <td class="acenter" width="26.64%"><p style="text-align:center">23 (71.9%)</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="31.62%"><p style="text-align:center">Total</p></td> 
      <td class="acenter" width="26.64%"><p style="text-align:center">32 (100%)</p></td> 
      <td class="acenter" width="26.64%"><p style="text-align:center">32 (100%)</p></td> 
     </tr> 
    </table>
   </table-wrap>
   <p>Duration of complaints in both the groups ranged from 8.5 ± 11.10 and 7.7 ± 11.0 in Holmium YAG laser and shock pulse group respectively (<xref ref-type="table" rid="table2">
     Table 2
    </xref>). Majority of our patients (56 out of 64), presented with flank pain followed by dysuria, fever and haematuria as chief complaint.</p>
   <table-wrap id="table2">
    <label>
     <xref ref-type="table" rid="table2">
      Table 2
     </xref></label>
    <caption>
     <title>
      <xref ref-type="bibr" rid="scirp.145069-"></xref>Table 2. Table showing pre-operative parameters assessed in the participants of both groups (HL—Holmium Laser Lithotripsy, SP—Shock pulse lithotripsy) with their mean and p-value.</title>
    </caption>
    <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
     <tr> 
      <td class="custom-bottom-td acenter" width="29.48%"><p style="text-align:center">Group</p></td> 
      <td class="custom-bottom-td acenter" width="26.72%"><p style="text-align:center">HL</p><p style="text-align:center">Mean ± Sd</p><p style="text-align:center">N = 32</p></td> 
      <td class="custom-bottom-td acenter" width="26.72%"><p style="text-align:center">SP</p><p style="text-align:center">Mean ± Sd</p><p style="text-align:center">N = 32</p></td> 
      <td class="custom-bottom-td acenter" width="17.08%"><p style="text-align:center">p Value*</p></td> 
     </tr> 
     <tr> 
      <td class="custom-top-td acenter" width="29.48%"><p style="text-align:center">Age year</p></td> 
      <td class="custom-top-td acenter" width="26.72%"><p style="text-align:center">39.3 ± 12.2</p></td> 
      <td class="custom-top-td acenter" width="26.72%"><p style="text-align:center">37.4 ±14.4</p></td> 
      <td class="custom-top-td acenter" width="17.08%"><p style="text-align:center">0.570</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="29.48%"><p style="text-align:center">Height m</p></td> 
      <td class="acenter" width="26.72%"><p style="text-align:center">1.7 ± 0.1</p></td> 
      <td class="acenter" width="26.72%"><p style="text-align:center">1.7 ±.06</p></td> 
      <td class="acenter" width="17.08%"><p style="text-align:center">0.975</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="29.48%"><p style="text-align:center">Weight kg</p></td> 
      <td class="acenter" width="26.72%"><p style="text-align:center">67.7 ± 13.7</p></td> 
      <td class="acenter" width="26.72%"><p style="text-align:center">62.8 ± 8.4</p></td> 
      <td class="acenter" width="17.08%"><p style="text-align:center">0.092</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="29.48%"><p style="text-align:center">BMI kgm<sup>2</sup></p></td> 
      <td class="acenter" width="26.72%"><p style="text-align:center">23.4 ± 3.4</p></td> 
      <td class="acenter" width="26.72%"><p style="text-align:center">21.81 ± 2.2</p></td> 
      <td class="acenter" width="17.08%"><p style="text-align:center">0.035</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="29.48%"><p style="text-align:center">Duration of complaints</p></td> 
      <td class="acenter" width="26.72%"><p style="text-align:center">8.5 ± 11.1</p></td> 
      <td class="acenter" width="26.72%"><p style="text-align:center">7.7 ± 11.0</p></td> 
      <td class="acenter" width="17.08%"><p style="text-align:center">0.786</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="29.48%"><p style="text-align:center">Preop urea</p></td> 
      <td class="acenter" width="26.72%"><p style="text-align:center">30.5 ± 19.6</p></td> 
      <td class="acenter" width="26.72%"><p style="text-align:center">30.9 ± 15.9</p></td> 
      <td class="acenter" width="17.08%"><p style="text-align:center">0.919</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="29.48%"><p style="text-align:center">Preop creatinine</p></td> 
      <td class="acenter" width="26.72%"><p style="text-align:center">1.2 ± 0.7</p></td> 
      <td class="acenter" width="26.72%"><p style="text-align:center">1.18 ± 0.7</p></td> 
      <td class="acenter" width="17.08%"><p style="text-align:center">0.985</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="29.48%"><p style="text-align:center">Post op urea</p></td> 
      <td class="acenter" width="26.72%"><p style="text-align:center">27.1 ± 10.4</p></td> 
      <td class="acenter" width="26.72%"><p style="text-align:center">31.8 ± 16.7</p></td> 
      <td class="acenter" width="17.08%"><p style="text-align:center">0.185</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="29.48%"><p style="text-align:center">Post op creatinine</p></td> 
      <td class="acenter" width="26.72%"><p style="text-align:center">1.1 ± 0.4</p></td> 
      <td class="acenter" width="26.72%"><p style="text-align:center">1.1 ± 0.5</p></td> 
      <td class="acenter" width="17.08%"><p style="text-align:center">0.969</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="29.48%"><p style="text-align:center">Preop creatinine clearance</p></td> 
      <td class="acenter" width="26.72%"><p style="text-align:center">92.1 ± 38.8</p></td> 
      <td class="acenter" width="26.72%"><p style="text-align:center">87.5 ± 40.9</p></td> 
      <td class="acenter" width="17.08%"><p style="text-align:center">0.648</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="29.48%"><p style="text-align:center">Post-op creatinine clearance</p></td> 
      <td class="acenter" width="26.72%"><p style="text-align:center">86.1 ± 26.6</p></td> 
      <td class="acenter" width="26.72%"><p style="text-align:center">84.3 ± 31.0</p></td> 
      <td class="acenter" width="17.08%"><p style="text-align:center">0.806</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="29.48%"><p style="text-align:center">Stone length (mm)</p></td> 
      <td class="acenter" width="26.72%"><p style="text-align:center">10.5 ± 2.8</p></td> 
      <td class="acenter" width="26.72%"><p style="text-align:center">9.3 ± 2.6</p></td> 
      <td class="acenter" width="17.08%"><p style="text-align:center">0.064</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="29.48%"><p style="text-align:center">Breadth (mm)</p></td> 
      <td class="acenter" width="26.72%"><p style="text-align:center">9.1 ± 2.1</p></td> 
      <td class="acenter" width="26.72%"><p style="text-align:center">8.6 ± 2.7</p></td> 
      <td class="acenter" width="17.08%"><p style="text-align:center">0.361</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="29.48%"><p style="text-align:center">Height of craniocaudal dimension (mm)</p></td> 
      <td class="acenter" width="26.72%"><p style="text-align:center">8.9 ± 1.9</p></td> 
      <td class="acenter" width="26.72%"><p style="text-align:center">8.9 ± 2.2</p></td> 
      <td class="acenter" width="17.08%"><p style="text-align:center">0.943</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="29.48%"><p style="text-align:center">Pre Stone volume (mm<sup>3</sup>)</p></td> 
      <td class="acenter" width="26.72%"><p style="text-align:center">492.6 ± 266.4</p></td> 
      <td class="acenter" width="26.72%"><p style="text-align:center">431.0 ± 316.1</p></td> 
      <td class="acenter" width="17.08%"><p style="text-align:center">0.402</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="29.48%"><p style="text-align:center">Pre stone density (HU)</p></td> 
      <td class="acenter" width="26.72%"><p style="text-align:center">927.8 ± 276.6</p></td> 
      <td class="acenter" width="26.72%"><p style="text-align:center">957.1 ± 188.8</p></td> 
      <td class="acenter" width="17.08%"><p style="text-align:center">0.623</p></td> 
     </tr> 
    </table>
   </table-wrap>
   <p>No significant difference in both groups in preoperative and postoperative urea and creatinine values. No significant difference elicited between preoperative and postoperative creatinine clearance.</p>
   <p>Radiological Analysis of Stone: There was no significant difference between the two groups with regards to dimensions of the stone. Stone volume of more than 50% of the study group assessed was found to be in the range of &lt;500 mm<sup>3</sup> with mean value of 492.62 ± 266.41 mm<sup>3</sup> and 431.0 ± 316.1 mm<sup>3</sup> respectively. Stone density which was measured in terms of HU was predominantly between 500 - 1000 HU with mean value of 927.8 ± 276.6 and 957.1 ± 188.8 in HL and SP group respectively (<xref ref-type="table" rid="table3">
     Table 3
    </xref>).</p>
   <p>Operating time was found to be shorter in SP group (36.8 ± 5.2 mins) as compared to HL group (64.7 ± 10.6 mins) with p value of &lt;0.05 (<xref ref-type="table" rid="table3">
     Table 3
    </xref>). The Time taken for stone fragmentation was found to be less in SP (32.7 ± 7.5 mins) when compared to HL (59.1 ± 10.4 mins) which in turn has a significant on total operating time (<xref ref-type="table" rid="table3">
     Table 3
    </xref>). Stone clearance of SP group was found to be 12.7 ± 8.2 mm3/min which is statistically significant when compared with HL group (p value-0.05). Intraoperatively we had 4 patients who had altered from our normal course of treatment. 3 of which were planned for other alternative operative intervention later due to stone migration.</p>
   <table-wrap id="table3">
    <label>
     <xref ref-type="table" rid="table3">
      Table 3
     </xref></label>
    <caption>
     <title>
      <xref ref-type="bibr" rid="scirp.145069-"></xref>Table 3. Table showing intra and post-operative parameters assessed in the participants of both groups (HL—Holmium Laser Lithotripsy, SP—Shock pulse lithotripsy) with their mean and p-value.</title>
    </caption>
    <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
     <tr> 
      <td rowspan="2" class="acenter" width="33.78%"><p style="text-align:center">Outcome</p></td> 
      <td class="acenter" width="51.46%" colspan="2"><p style="text-align:center">Procedure performed</p></td> 
      <td rowspan="2" class="acenter" width="14.76%"><p style="text-align:center">p Value<sup>#</sup></p></td> 
     </tr> 
     <tr> 
      <td class="custom-bottom-td custom-top-td acenter" width="25.72%"><p style="text-align:center">HL</p></td> 
      <td class="custom-bottom-td custom-top-td acenter" width="25.74%"><p style="text-align:center">SP</p></td> 
     </tr> 
     <tr> 
      <td class="custom-top-td acenter" width="33.78%"><p style="text-align:center">Stone free</p></td> 
      <td class="custom-top-td acenter" width="25.72%"><p style="text-align:center">29 (90.6%)</p></td> 
      <td class="custom-top-td acenter" width="25.74%"><p style="text-align:center">29 (90.6%)</p></td> 
      <td rowspan="5" class="custom-top-td acenter" width="14.76%"><p style="text-align:center">0.280</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="33.78%"><p style="text-align:center">Failed</p></td> 
      <td class="acenter" width="25.72%"><p style="text-align:center">1 (3.1%)</p></td> 
      <td class="acenter" width="25.74%"><p style="text-align:center">1 (3.1%)</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="33.78%"><p style="text-align:center">PA</p></td> 
      <td class="acenter" width="25.72%"><p style="text-align:center">2 (6.25%)</p></td> 
      <td class="acenter" width="25.74%"><p style="text-align:center">1 (3.1%)</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="33.78%"><p style="text-align:center">CIRF</p></td> 
      <td class="acenter" width="25.72%"><p style="text-align:center">0 (0%)</p></td> 
      <td class="acenter" width="25.74%"><p style="text-align:center">1 (3.1%)</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="33.78%"><p style="text-align:center">Total</p></td> 
      <td class="acenter" width="25.72%"><p style="text-align:center">32 (100%)</p></td> 
      <td class="acenter" width="25.74%"><p style="text-align:center">32 (100%)</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="33.78%"><p style="text-align:center">Operating time in mins</p></td> 
      <td class="acenter" width="25.72%"><p style="text-align:center">64.7 ± 10.6</p></td> 
      <td class="acenter" width="25.74%"><p style="text-align:center">36.8 ± 5.2</p></td> 
      <td class="acenter" width="14.76%"><p style="text-align:center">&lt;0.001</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="33.78%"><p style="text-align:center">Time taken for stone fragmentation in mins</p></td> 
      <td class="acenter" width="25.72%"><p style="text-align:center">59.1 ± 10.4</p></td> 
      <td class="acenter" width="25.74%"><p style="text-align:center">32.7 ± 7.5</p></td> 
      <td class="acenter" width="14.76%"><p style="text-align:center">&lt;0.001</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="33.78%"><p style="text-align:center">Stone clearance rate mm<sup>3</sup>/min</p></td> 
      <td class="acenter" width="25.72%"><p style="text-align:center">8.03 ± 3.7</p></td> 
      <td class="acenter" width="25.74%"><p style="text-align:center">12.7 ± 8.2</p></td> 
      <td class="acenter" width="14.76%"><p style="text-align:center">0.05</p></td> 
     </tr> 
    </table>
   </table-wrap>
   <p>No complications recorded on POD-0. On POD-1, 4 participants developed grade 2 complication and 1 developed grade 1 complication (<xref ref-type="table" rid="table4">
     Table 4
    </xref>). Out of 32 participants in each arm, 29 (90.6%) in Holmium laser group and 31 (96.9%) in shock pulse group did not experience any complication on POD-10.</p>
   <table-wrap id="table4">
    <label>
     <xref ref-type="table" rid="table4">
      Table 4
     </xref></label>
    <caption>
     <title>
      <xref ref-type="bibr" rid="scirp.145069-"></xref>Table 4. Complications observed in the participants of both groups (HL—Holmium Laser Lithotripsy, SP—Shock pulse lithotripsy) graded as per Clavien Dindo classification.</title>
    </caption>
    <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
     <tr> 
      <td class="custom-bottom-td acenter" width="28.14%"><p style="text-align:center">Complications (Clavien dindo)</p></td> 
      <td class="custom-bottom-td acenter" width="20.58%"><p style="text-align:center">Intraoperative period</p></td> 
      <td class="custom-bottom-td acenter" width="12.93%"><p style="text-align:center">POD-0</p></td> 
      <td class="custom-bottom-td acenter" width="12.93%"><p style="text-align:center">POD-1</p></td> 
      <td class="custom-bottom-td acenter" width="12.95%"><p style="text-align:center">POD-10</p></td> 
      <td class="custom-bottom-td acenter" width="12.47%"><p style="text-align:center">After 4 weeks</p></td> 
     </tr> 
     <tr> 
      <td class="custom-top-td acenter" width="28.14%"><p style="text-align:center">Grade 1</p></td> 
      <td class="custom-top-td acenter" width="20.58%"><p style="text-align:center">0</p></td> 
      <td class="custom-top-td acenter" width="12.93%"><p style="text-align:center">0</p></td> 
      <td class="custom-top-td acenter" width="12.93%"><p style="text-align:center">1</p></td> 
      <td class="custom-top-td acenter" width="12.95%"><p style="text-align:center">0</p></td> 
      <td class="custom-top-td acenter" width="12.47%"><p style="text-align:center">0</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="28.14%"><p style="text-align:center">Grade 2</p></td> 
      <td class="acenter" width="20.58%"><p style="text-align:center">0</p></td> 
      <td class="acenter" width="12.93%"><p style="text-align:center">0</p></td> 
      <td class="acenter" width="12.93%"><p style="text-align:center">4</p></td> 
      <td class="acenter" width="12.95%"><p style="text-align:center">0</p></td> 
      <td class="acenter" width="12.47%"><p style="text-align:center">0</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="28.14%"><p style="text-align:center">Grade 3</p></td> 
      <td class="acenter" width="20.58%"><p style="text-align:center">3</p></td> 
      <td class="acenter" width="12.93%"><p style="text-align:center">0</p></td> 
      <td class="acenter" width="12.93%"><p style="text-align:center">0</p></td> 
      <td class="acenter" width="12.95%"><p style="text-align:center">2</p></td> 
      <td class="acenter" width="12.47%"><p style="text-align:center">0</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="28.14%"><p style="text-align:center">Grade 4</p></td> 
      <td class="acenter" width="20.58%"><p style="text-align:center">0</p></td> 
      <td class="acenter" width="12.93%"><p style="text-align:center">0</p></td> 
      <td class="acenter" width="12.93%"><p style="text-align:center">0</p></td> 
      <td class="acenter" width="12.95%"><p style="text-align:center">0</p></td> 
      <td class="acenter" width="12.47%"><p style="text-align:center">0</p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="28.14%"><p style="text-align:center">Grade 5</p></td> 
      <td class="acenter" width="20.58%"><p style="text-align:center">0</p></td> 
      <td class="acenter" width="12.93%"><p style="text-align:center">0</p></td> 
      <td class="acenter" width="12.93%"><p style="text-align:center">0</p></td> 
      <td class="acenter" width="12.95%"><p style="text-align:center">0</p></td> 
      <td class="acenter" width="12.47%"><p style="text-align:center">0</p></td> 
     </tr> 
    </table>
   </table-wrap>
  </sec><sec id="s5">
   <title>5. Discussion</title>
   <sec id="s5_1">
    <title>5.1. Stone Size and Stone Density</title>
    <p>Mean pre procedural stone volume was found to be 492.6 ± 266.4 and 431.0 ± 316.1 in Holmium YAG laser and shock pulse group respectively. Mean pre procedural Stone density was found to be 927.8 ± 276.6 and 957.1 ± 188.8 in Holmium YAG laser and shock pulse group respectively. Stone density can help in identifying the composition of the stone. Studies done by Kawahara et al. and Halinski et al., it has been found that majority of the stones found in Ureter contained Calcium and their Hounsfield units (HU) were more than 1000 <xref ref-type="bibr" rid="scirp.145069-11">
      [11]
     </xref> <xref ref-type="bibr" rid="scirp.145069-12">
      [12]
     </xref>.</p>
   </sec>
   <sec id="s5_2">
    <title>5.2. Intraoperative Parameters</title>
    <p>Intraoperatively the operating time was found to be shorter in patients undergoing Shock pulse lithotripsy (36.8 ± 5.2 mins) in comparison to Holmium YAG laser group (64.7 ± 10.6 mins) and was found to be statistically significant on analysis (p value &lt; 0.05). In a prospective randomized trial by Linjin Li et al., the mean operating time was found to be operative time 28 ± 9.2 vs 41 ±12.4, P = 0.001 in Holmium YAG laser and pneumatic lithotripsy group but this study has can be carried out for middle and distal ureteric calculi which can explain the much shorter operating time in Holmium YAG Laser group as the access distance is shorter . The time taken for stone fragmentation or stone disintegration time was also shorter in shock pulse (32.7 ± 7.5 mins) group as compared to Holmium laser group (59.1 ± 10.4 mins) with p value &lt; 0.05 . Stone clearance was significantly higher in Shock pulse group 12.7 ± 8.2 mm<sup>3</sup>/mins when compared to Holmium YAG Laser group 8.03 ± 3.7 mm<sup>3</sup>/mins with p value = 0.05. This is in agreement with previous study by Rajeev TP et al. where stone clearance rate of shock pulse lithotripsy was comparatively better than Holmium YAG Laser via PCNL <xref ref-type="bibr" rid="scirp.145069-14">
      [14]
     </xref>. No other studies has compared the efficacy of shock pulse and Holmium Laser. Shock pulse lithotripsy is efficacious when compared to Holmium Laser in terms of stone clearance rate. Reason for shock pulse being efficacious than holmium laser can be attributed to the superior fragmentation effect of pneumatic component combined with ultrasonic component which can help in evacuation of stone fragments.</p>
    <p>Stone free rate was found to be 87.5% in Holmium YAG laser group and 90.6% in Shock pulse with p value of 0.280 (no statistically significant difference). CIRF rate was 3.1 % in Shock pulse group. Failure rates were 3.33% in Holmium laser group and 3.22% in shock pulse group.</p>
    <p>In a metanalysis by Matlaga et al., Stone free rate in proximal ureteral stone following Ureteroscopic lithotripsy was found to be 96% initially which increased upto 100% on a 13-week follow up <xref ref-type="bibr" rid="scirp.145069-15">
      [15]
     </xref>.</p>
    <p>As per AUA guidelines report the stone free rate for ureteroscopy was found to be 81%. Among different modalities of lithotripsy Holmium YAG laser was found to have higher stone free rate till the advent of shock pulse. In a study by Rajeev TP et al. where he has analyzed the stone free rate among various energy modalities in PCNL, has found stone free rate to be high in shock pulse (82.35 %) as compared to Holmium YAG laser (81.25%) . Failure rate was found to be 5.89% in shock pulse group and 6.25% in Holmium YAG laser group in treatment of renal stones with PCNL . This difference in failure rates can be because of the difference in procedure and sample size used.</p>
   </sec>
   <sec id="s5_3">
    <title>5.3. Complications</title>
    <p>We observed complications during the intraoperative period, Post operative day-0, 1, 10 and after 4weeks. These complications were graded using Clavien Dindo classification. Intraoperatively, 3 of our participants developed grade 3 complications following which the proposed procedure was changed to another procedure. On POD-0 no complications were noted. On POD-1 one participant developed grade 1 and 4 developed grade 2 complication. On POD-10, 2 patients were identified to have residual stone &gt; 2 mm in NCCT KUB following which they were termed as “Failure”. No statistically significant complications noted between the two groups. Further studies are required to explore the complications following shock pulse lithotripsy. However, the quality of life (QoL) was not affected as participants were able to resume activities on POD-1 and are discharged on the same day. Participants who developed complications were able to carry out their daily activities but had increased stay in the hospital.</p>
   </sec>
   <sec id="s5_4">
    <title>5.4. Limitations</title>
    <p>Follow up beyond 4 weeks must be carried out further to identify further complications and recurrent formation of stones which is lacking in our follow up period. Further analysis of these two lithotripters should be carried out with a larger sample size. The results of the procedure can be affected by a number of circumstances, and this study did not assess the experience of the surgeon. Furthermore, the study’s objective was to analyse the effectiveness of two lithotripters; additional research may be required to examine other variables that may affect the result.</p>
   </sec>
  </sec><sec id="s6">
   <title>6. Conclusion</title>
   <p>With innovations in energy modalities used in lithotripters, the technical factors are improving at a greater pace. From our study, we can conclude that shock pulse is efficacious than Holmium YAG Laser lithotripsy in terms of stone clearance rate which in turn has resulted in decreased operating time which can be beneficial in planning more number of operative procedures. Surgeons must stay updated on new technology and techniques in order to deliver tailored therapies for each patient with the best possibility of success.</p>
  </sec><sec id="s7">
   <title>Acknowledgements</title>
   <p>“I am indebted to my father for living, but to my teacher for living well”—Alexander the Great</p>
   <p>Completion of this humble work which at times appeared mammoth could not have been accomplished without those who have given me continuous support, motivation, and prompt help throughout this memorable journey.</p>
   <p>I owe my most sincere gratitude to my chief guide, Dr. Ankur Mittal who has been a source of great inspiration, constant intellectual stimulation, and expert advice throughout this study.</p>
   <p>I express my immense gratitude to my co-guides, Dr. Vikas Kumar Panwar, Dr. Poonam Sherwani and Dr. Ajeet Singh Bhadoria for their masterly advice, valuable suggestions, and feedback during this thesis.</p>
   <p>I sincerely express my gratitude to the whole Urology team who have helped me in my thesis.</p>
   <p>A special word of thanks to all my patients and family members who have been a constant source of motivation and have cooperated with patience.</p>
   <p>I would also like to thank my seniors, colleagues, and juniors for their contributions and help during the thesis preparation. I sincerely acknowledge the help offered by the entire staff and team of the Urology and the Department of General Surgery throughout this study.</p>
  </sec><sec id="s8">
   <title>Authors and Contributions</title>
   <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
    <tr> 
     <td class="acenter" width="10.00%"><p style="text-align:center">1</p></td> 
     <td class="aleft" width="74.93%"><p style="text-align:left">Chezhian Subramanian—MS Gen Surgery, Junior Resident, Department of Urology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India</p></td> 
     <td class="aleft" width="50.91%"><p style="text-align:left">Principal investigator—Data collection, Data acquisition and entry, Data analysis and manuscript writing</p></td> 
    </tr> 
    <tr> 
     <td class="acenter" width="10.00%"><p style="text-align:center">2</p></td> 
     <td class="aleft" width="74.93%"><p style="text-align:left">Ankur Mittal—M Ch Urology, Associate Professor, Department of Urology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India</p></td> 
     <td class="aleft" width="50.91%"><p style="text-align:left">Conception of idea and study design, data analysis and review of the manuscript</p></td> 
    </tr> 
    <tr> 
     <td class="acenter" width="10.00%"><p style="text-align:center">3</p></td> 
     <td class="aleft" width="74.93%"><p style="text-align:left">Vikas Kumar Panwar—M Ch Urology, Assistant Professor, Department of Urology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India</p></td> 
     <td class="aleft" width="50.91%"><p style="text-align:left">Review of manuscript and Data analysis</p></td> 
    </tr> 
    <tr> 
     <td class="acenter" width="10.00%"><p style="text-align:center">4</p></td> 
     <td class="aleft" width="74.93%"><p style="text-align:left">Gurpremjit Singh—M Ch Urology, Senior Resident, Department of Urology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India</p></td> 
     <td class="aleft" width="50.91%"><p style="text-align:left">Review of manuscript and Data analysis</p></td> 
    </tr> 
    <tr> 
     <td class="acenter" width="10.00%"><p style="text-align:center">5</p></td> 
     <td class="aleft" width="74.93%"><p style="text-align:left">Omang Agrawal—MS Gen Surgery, Senior Resident, Department of Urology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India</p></td> 
     <td class="aleft" width="50.91%"><p style="text-align:left">Review of manuscript and Data analysis</p></td> 
    </tr> 
   </table>
  </sec>
 </body><back>
  <ref-list>
   <title>References</title>
   <ref id="scirp.145069-ref1">
    <label>1</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Okuyama, M., Yamaguchi, S., Kita, M., Kato, Y., Hashimoto, H., Kakizaki, H., et al. (2007) Clinical Characteristics of Urolithiasis with Stone Analysis Conducted over a 26-Year Period. The Japanese Journal of Urology, 98, 9-16. &gt;https://doi.org/10.5980/jpnjurol1989.98.9
    </mixed-citation>
   </ref>
   <ref id="scirp.145069-ref2">
    <label>2</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Liu, Y., Chen, Y., Liao, B., Luo, D., Wang, K., Li, H., et al. (2018) Epidemiology of Urolithiasis in Asia. Asian Journal of Urology, 5, 205-214. &gt;https://doi.org/10.1016/j.ajur.2018.08.007
    </mixed-citation>
   </ref>
   <ref id="scirp.145069-ref3">
    <label>3</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Tiselius, H.G., Ackermann, D., Alken, P., Buck, C., Conort, P. and Gallucci, M. (2001) Guidelines on Urolithiasis. European Urology, 40, 362-371. &gt;https://doi.org/10.1159/000049803
    </mixed-citation>
   </ref>
   <ref id="scirp.145069-ref4">
    <label>4</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Jayawardene, M.D., Balagobi, B., Ambegoda, A.L.A.M.C., Vidanapathirana, S., Wijayagunawardane, G.W.A.S.K., Senthan, V., et al. (2017) Outcome of Uncomplicated Ureteric Calculi Managed with Medical Expulsive Therapy in the Outpatient Clinic of a Urology Unit in Sri Lanka. BMC Research Notes, 10, Article No. 636. &gt;https://doi.org/10.1186/s13104-017-2974-1
    </mixed-citation>
   </ref>
   <ref id="scirp.145069-ref5">
    <label>5</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Jagannath, K., Gupta, A.K. and Srinivasan, N. (2019) A Study on Ureteric Calculi in a Rural Tertiary Care Centre. International Surgery Journal, 6, Article No. 1312. &gt;https://doi.org/10.18203/2349-2902.isj20191268
    </mixed-citation>
   </ref>
   <ref id="scirp.145069-ref6">
    <label>6</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Pickard, R., Starr, K., MacLennan, G., Lam, T., Thomas, R., Burr, J., et al. (2015) Medical Expulsive Therapy in Adults with Ureteric Colic: A Multicentre, Randomised, Placebo-Controlled Trial. The Lancet, 386, 341-349. &gt;https://doi.org/10.1016/s0140-6736(15)60933-3
    </mixed-citation>
   </ref>
   <ref id="scirp.145069-ref7">
    <label>7</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Bapat, S.S., Pai, K.V., Purnapatre, S.S., Yadav, P.B. and Padye, A.S. (2007) Comparison of Holmium Laser and Pneumatic Lithotripsy in Managing Upper-Ureteral Stones. Journal of Endourology, 21, 1425-1428. &gt;https://doi.org/10.1089/end.2006.0350
    </mixed-citation>
   </ref>
   <ref id="scirp.145069-ref8">
    <label>8</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ordon, M., Andonian, S., Blew, B., Schuler, T., Chew, B. and Pace, K.T. (2015) CUA Guideline: Management of Ureteral Calculi. Canadian Urological Association Journal, 9, 837-851. &gt;https://doi.org/10.5489/cuaj.3483
    </mixed-citation>
   </ref>
   <ref id="scirp.145069-ref9">
    <label>9</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Preminger, G.M., Tiselius, H., Assimos, D.G., Alken, P., Buck, C., Gallucci, M., et al. (2007) 2007 Guideline for the Management of Ureteral Calculi. Journal of Urology, 178, 2418-2434. &gt;https://doi.org/10.1016/j.juro.2007.09.107
    </mixed-citation>
   </ref>
   <ref id="scirp.145069-ref10">
    <label>10</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Hou, C., Lin, Y., Juang, H., Chang, P., Chen, C., Yang, P., et al. (2020) Effect of Ureteral Calculus in Outpatients Receiving Semirigid Ureteroscope Laser Lithotripsy. Medicine, 99, e19324. &gt;https://doi.org/10.1097/md.0000000000019324
    </mixed-citation>
   </ref>
   <ref id="scirp.145069-ref11">
    <label>11</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Kawahara, T., Miyamoto, H., Ito, H., Terao, H., Kakizoe, M., Kato, Y., et al. (2015) Predicting the Mineral Composition of Ureteral Stone Using Non-Contrast Computed Tomography. Urolithiasis, 44, 231-239. &gt;https://doi.org/10.1007/s00240-015-0823-z
    </mixed-citation>
   </ref>
   <ref id="scirp.145069-ref12">
    <label>12</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Hali’nski, A., Bhatti, K.H., Boeri, L., Cloutier, J., Davidoff, K., Elqady, A., et al. (2021) Stone Composition of Renal Stone Formers from Different Global Regions. Archivio Italiano di Urologia e Andrologia, 93, 307-312. &gt;https://doi.org/10.4081/aiua.2021.3.307
    </mixed-citation>
   </ref>
   <ref id="scirp.145069-ref13">
    <label>13</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Li, L., Pan, Y., Weng, Z., Bao, W., Yu, Z. and Wang, F. (2015) A Prospective Randomized Trial Comparing Pneumatic Lithotripsy and Holmium Laser for Management of Middle and Distal Ureteral Calculi. Journal of Endourology, 29, 883-887. &gt;https://doi.org/10.1089/end.2014.0856
    </mixed-citation>
   </ref>
   <ref id="scirp.145069-ref14">
    <label>14</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Rajeev, T.P., Pratihar, S.K., Sarma, D., Baruah, S.J., Barua, S.K., Bagchi, P.K., et al. (2018) A Comparative Study between Holmium Laser, Pneumatic Lithotripsy and Shock Pulse in Terms of Efficacy and Safety in Percutaneous Nephrolithotomy (PCNL). 1-8.
    </mixed-citation>
   </ref>
   <ref id="scirp.145069-ref15">
    <label>15</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Matlaga, B.R., Jansen, J.P., Meckley, L.M., Byrne, T.W. and Lingeman, J.E. (2012) Treatment of Ureteral and Renal Stones: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials. Journal of Urology, 188, 130-137. &gt;https://doi.org/10.1016/j.juro.2012.02.2569
    </mixed-citation>
   </ref>
  </ref-list>
 </back>
</article>